Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment”

Meijide Míguez, Héctor; Montes García, Iñaki; Ochando Gómez, Miguel; García Merino, Isabel M.; Cano, Emilio L.; De La Torre, Alejandro

doi:10.1016/j.regg.2023.04.003

array:23 ["pii" => "S0211139X23000689" "issn" => "0211139X" "doi" => "10.1016/j.regg.2023.04.003" "estado" => "S300" "fechaPublicacion" => "2023-05-01" "aid" => "1368" "copyright" => "SEGG" "copyrightAnyo" => "2023" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Esp Geriatr Gerontol. 2023;58:175" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemAnterior" => array:18 [ "pii" => "S0211139X23000677" "issn" => "0211139X" "doi" => "10.1016/j.regg.2023.04.004" "estado" => "S300" "fechaPublicacion" => "2023-05-01" "aid" => "1369" "copyright" => "SEGG" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Esp Geriatr Gerontol. 2023;58:174" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "174" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Inmunogenicidad, efectividad y seguridad de la vacuna COVID-19 en adultos mayores que viven en hogares geriátricos: comentario" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Amnuay Kleebayoon, Viroj Wiwanitkit" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Amnuay" "apellidos" => "Kleebayoon" ] 1 => array:2 [ "nombre" => "Viroj" "apellidos" => "Wiwanitkit" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211139X23000677?idApp=UINPBA00004N" "url" => "/0211139X/0000005800000003/v1_202306091040/S0211139X23000677/v1_202306091040/en/main.assets" ] "asociados" => array:1 [ 0 => array:17 [ "pii" => "S0211139X2400088X" "issn" => "0211139X" "doi" => "10.1016/j.regg.2024.101554" "estado" => "S300" "fechaPublicacion" => "2024-11-01" "aid" => "101554" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "err" "cita" => "Rev Esp Geriatr Gerontol. 2024;59:" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:8 [ "idiomaDefecto" => true "cabecera" => "Fe de errores" "titulo" => "Fe de errores sobre artículos publicados en Revista Española de Geriatría y Gerontología" "tienePdf" => "es" "tieneTextoCompleto" => "es" "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Erratum to articles published in Revista Española de Geriatría y Gerontología" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211139X2400088X?idApp=UINPBA00004N" "url" => "/0211139X/0000005900000006/v1_202411040626/S0211139X2400088X/v1_202411040626/es/main.assets" ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment”" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "175" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Héctor Meijide Míguez, Iñaki Montes García, Miguel Ochando Gómez, Isabel M. García Merino, Emilio L. Cano, Alejandro De La Torre" "autores" => array:6 [ 0 => array:3 [ "nombre" => "Héctor" "apellidos" => "Meijide Míguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Iñaki" "apellidos" => "Montes García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Miguel" "apellidos" => "Ochando Gómez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Isabel M." "apellidos" => "García Merino" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "Emilio L." "apellidos" => "Cano" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "e" "identificador" => "aff5" ] 1 => array:2 [ "etiqueta" => "f" "identificador" => "aff0025" ] ] ] 5 => array:4 [ "nombre" => "Alejandro" "apellidos" => "De La Torre" "email" => array:1 [ 0 => "alejandro.delatorre@imbanaco.com.co" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "g" "identificador" => "aff0030" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:7 [ 0 => array:3 [ "entidad" => "Department of Internal Medicine, Hospital Quironsalud A Coruña, A Coruña, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Executive Director, Residencia Dulcinea, Grupo Quirónsalud, Alcázar de San Juan, Ciudad. Real, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Technical Director of Clinical Laboratory, Health Diagnostic, Grupo Quironsalud, Madrid, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Department of Research and Innovation, Grupo Quirónsalud, Madrid, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Research Centre for Intelligent Information Technologies (CETINIA-DSLAB), Rey Juan Carlos University, Móstoles, Spain" "etiqueta" => "e" "identificador" => "aff5" ] 5 => array:3 [ "entidad" => "Quantitative Methods and Socio-economic Development Group, Institute for Regional Development (IDR), University of Castilla-La Mancha (UCLM), Albacete, Spain" "etiqueta" => "f" "identificador" => "aff0025" ] 6 => array:3 [ "entidad" => "Scientific Director, Clinica Imbanaco, Grupo Quironsalud, Cali, Valle del Cauca, Colombia" "etiqueta" => "g" "identificador" => "aff0030" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta de los autores: «Inmunogenicidad, efectividad y seguridad de la vacuna COVID-19 en adultos mayores que viven hogares geriátricos: comentario»" ] ] "textoCompleto" => "We have carefully read the reply by Kleebayoon A. et al. and their comments about our work on immunization against Covid 19 in elderly population. The temporality of this and the amount of scientific information in recent years means that any study in real life is qualified in a very short period of time by new evidence. Having said this, and according to the recent literature today nobody doubts about the safety or efficacy of the available vaccines against Covid 19, since it has been validated in numerous settings, including the elderly population.<a class="elsevierStyleCrossRef" href="#bib0025">1</a>Kleebayoon A. et al. focus on paucisymptomatic or silent patients with Covid 19. At the time of the covid-19 infection boom, some people might have no symptoms at all, but could still infect others (asymptomatic transmission). In addition, there was a consensus regarding the involvement of these people, in terms of epidemiological risk, in the silent transmission of the new coronaviruses to other people and the subclinical spread of the disease in the apparently healthy population. Asymptomatic patients never knew they had the infection. Therefore, their ability to infect others always depended on their behavior to comply with preventive actions.On the other hand, it is worthy highlight that immunization does not have the objective of reducing contagion (neither paucisymptomatic covid-19 or silent covid-19) it rather seeks, and data confirm, that vaccines contributed to reduce the risk of severe illness from Covid 19, hospitalization and death.<a class="elsevierStyleCrossRef" href="#bib0030">2</a> Thanks to vaccines, we have witnessed a drastic change of scenery in the last year, both in nursing homes and in hospitals, with a great impact on reduction of morbidity and mortality from Covid 19. This allowed, not only to preserve lives, but also generating savings in health systems, allowing people and countries to return to normal life.In our study, as in others conducted in nursing home residents, a history of SARS-CoV-2 infection before vaccination was the strongest predictor of the antibody titer response.<a class="elsevierStyleCrossRef" href="#bib0035">3</a> Furthermore, prior SARS-CoV-2 infection may enhance the vaccine response rate and this response may differ from the results observed in clinical trials conducted before the infection became prevalent in the population.Lastly, although more severe courses of disease from Covid 19 associated with age, male gender and the presence of certain comorbidities are well documented, we agree with Kleebayoon A. et al. that more studies are needed that provide evidence about the intrinsic characteristics of the virus, as well as host genetic factors.<a class="elsevierStyleCrossRef" href="#bib0040">4</a> This research would help to better explain the heterogeneity of the virus." "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0025" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.D. Moreira Jr." 1 => "N. Kitchin" 2 => "X. Xu" 3 => "S.S. Dychter" 4 => "S. Lockhart" 5 => "A. Gurtman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2200674" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2022" "volumen" => "386" "paginaInicial" => "1910" "paginaFinal" => "1921" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35320659" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0030" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case–control study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Lopez Bernal" 1 => "N. Andrews" 2 => "C. Gower" 3 => "C. Robertson" 4 => "J. Stowe" 5 => "E. Tessier" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "BMJ" "fecha" => "2021" "volumen" => "373" "paginaInicial" => "n1088" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0035" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Previous SARS-CoV-2 infection, age, and frailty are associated with 6-month vaccine induced anti-spike antibody titer in nursing home residents" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.H. Dyer" 1 => "C. Noonan" 2 => "M. McElheron" 3 => "I. Batten" 4 => "C. Reddy" 5 => "E. Connolly" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Med Direct Assoc" "fecha" => "2022" "volumen" => "23" "paginaInicial" => "434" "paginaFinal" => "439" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0040" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C. Anastassopoulou" 1 => "Z. Gkizarioti" 2 => "G.P. Patrinos" 3 => "A. Tsakris" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s40246-020-00290-4" "Revista" => array:5 [ "tituloSerie" => "Hum Genomics" "fecha" => "2020" "volumen" => "14" "paginaInicial" => "40" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33092637" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/0211139X/0000005800000003/v1_202306091040/S0211139X23000689/v1_202306091040/en/main.assets" "Apartado" => array:4 [ "identificador" => "7718" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas al Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/0211139X/0000005800000003/v1_202306091040/S0211139X23000689/v1_202306091040/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211139X23000689?idApp=UINPBA00004N"]

ISSN: 0211-139X

Revista Española de Geriatría y Gerontología es el Órgano de Expresión de la Sociedad, una de las sociedades que está experimentando mayor crecimiento por lo que respecta al número de afiliados. Revista fundada en 1966, lo que la convierte en la revista decana de la especialidad en lengua castellana. Se publican principalmente artículos Originales de investigación y Revisiones, al igual que Notas clínicas, Informes, Protocolos y Guías de actuación consensuados por la Sociedad. Cubre todas las áreas de la medicina, pero siempre desde el punto de vista de la atención al paciente anciano. Los trabajos siguen un proceso de peer review, revisión por pares externos.

Ver más Opción Open Access

Indexada en:

Excerpta Medica/EMBASE, IBECS, IME, SCOPUS y MEDLINE/PubMed

Artículo

Opciones para acceder a los textos completos de la publicación Revista Española de Geriatría y Gerontología

Suscriptor

Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".

Suscribirse a:

Revista Española de Geriatría y Gerontología

Más información

Comprar

Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 19,34 €

Comprar ahora

Contactar

Teléfono para suscripciones e incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España

932 415 960

Llamadas desde fuera de España

+34 932 415 960

E-mail

atencionalcliente@elsevier.com

Publique en

Revista Española de Geriatría y Gerontología

Artículos destacados

Guía para escribir un artículo científico

Herramientas

Artículos
recomendados

Immunogenicity, effectiveness and safety of COVID-19...

Rev Esp Geriatr Gerontol. 2023;58:125-33

Revista Española de Geriatría y Gerontología se adhiere a los principios y procedimientos dictados por el Committee on Publication Ethics (COPE)
www.publicationethics.org.

Artículos de acceso gratuito

Fe de errores sobre artículos publicados en Revista...

Rev Esp Geriatr Gerontol. 2024;59:

In memoriam del Dr. Juan José Solano...

Rev Esp Geriatr Gerontol. 2024;59:

Indexada en:

Síguenos:

Suscribirse:

Artículo

Indexada en:

Síguenos:

Suscribirse:

Artículo

Suscríbase a la newsletter